Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Tuhina_Neogi
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Tuhina_Neogi
-
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
Join the Rheumatism Society of DC for Gout 2020. Wednesday February 12. Looking forwards to hosting
@Tuhina_Neogipic.twitter.com/JXUMmVA1H0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
SWHR enjoyed hosting experts on
#osteoarthritis and#pain and we are eager to continue our engagement in this topic and raise awareness of the gaps in research, treatment, and care. Thank you@Tuhina_Neogi and@AM_Malf for joining us!https://twitter.com/Tuhina_Neogi/status/1222292189692223488 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
The ACR is now accepting applications for the 2020 Rheumatology Research Workshop. Early career investigators are encouraged to apply for this opportunity. The deadline to apply is Feb. 10. Learn more → https://acr.tw/2RE0jDt pic.twitter.com/W8YuFpu328
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Fun day with
@AM_Malf at@SWHR panel meeting on#osteoarthritis pain & understanding sex differences. Huge knowledge gaps and research agenda identified. 1st steps for clinical studies: report data stratified by sex. 1st steps for basic studies: report sex of animals studied.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
Dear Friends, here is my 2nd video on "Who Gets Myositis" in the
#Myositis101 for patients series, where I talk about how common is myositis as well as age, gender, race/ethnicities, etc of myositis. Next video is on risk factors of myositis - any guesses? https://youtu.be/YhtgYRJj_8U pic.twitter.com/VM68JKym2U
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
Come work with us at
@OrACORe_BWH! Applications open for our NIH funded T32! There are citizenship requirements so take a look at the app and please reach out with questions


@OARSI_YIhttps://twitter.com/OrACORe_BWH/status/1208416842118828033 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
FY 2020 Funding Plan | NIAMS Updated January 24, 2020 "The interim funding plan below for research and training grants represents the most current information as of the date cited above"https://buff.ly/2DAr6rQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
Down on your knees. Symptomatic or radiographic knee
#osteoarthritis increases (2X) risk of all‐cause mortality. Increased risk of mortality partially mediated through its effect on disability and physical effects on quality of life.https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24151#.Xi-VkLr3CPo.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
In epidemiology, women make up the majority of first authors but cited far less than male authors: Study by
@eschisterman1 et al. looks at gender disparities in the field. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5285305/ …#SPCHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
#goutguidelines-Target UA<6,
allopurinol to >300mg if needed even in CKD, start low dose and
as needed, consider screening Asians/Blacks for HLAB*5801 as that
risk for sev allergic rxn. Nephrologists should lead CKD gout mgmt as CKD pts are affected more and often under Rxhttps://twitter.com/tuhina_neogi/status/1221071679490793472 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
Our paper on antihypertensive drug and
#gout risk from the#allhat trial is out! Amlodipine lowers risk compared to Lisinopril! Helpful for#hypertension tx in adults with gout.@BIDMC_Medicine@BIDMChealth@bethisraellaheyhttps://pdfs.journals.lww.com/jhypertension/9000/00000/the_effects_of_antihypertensive_class_on_gout_in.97048.pdf …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Yes!! The message is getting out: Updated
#gout guidelines: Don’t let kidney function dictate#allopurinol dosing | MDedge Rheumatology @ACRheumhttps://www.mdedge.com/rheumatology/article/213863/gout/updated-gout-guidelines-dont-let-kidney-function-dictate …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Good luck to our medical colleagues on the frontlines managing this outbreak. (The majority of transmissions for SARS and MERS was nosocomial) https://www.nejm.org/doi/full/10.1056/NEJMp2000929 …pic.twitter.com/L0mKqAV6UM
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Coronavirus outbreak in China: reminds me of when I was a medical trainee in Toronto during SARS - I was scared to go to work. Toronto Board of Health did a great job - importance of public health and
#epidemiology. Another Decade, Another Coronavirushttps://www.nejm.org/doi/full/10.1056/NEJMe2001126#.Xit1mtgsZf0.twitter …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
Insurers and funders take note. Budget Impact of Funding an Intensive Diet and Exercise Program for Overweight and Obese Patients With Knee
#Osteoarthritis. Demonstrates affordability to support efficacy and cost-effectiveness@OrACORe_BWHhttps://onlinelibrary.wiley.com/doi/10.1002/acr2.11090?elq_mid=42066&elq_cid=1422684&elqCampaignId=26548&utm_campaign=26548&utm_source=eloquaEmail&utm_medium=email&utm_content=Email-Research-IssueAlert-ACRO_1-22-20&elqTrackId=083e086579414a6ab62e6d12526f3fae&elq=4b97a894d62f49daa25f81a8ea778472&elqaid=42066&elqat=1#.XinnEY14FFU.twitter …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Know of a project manager looking for a new opportunity? Come work with us on exciting
#osteoarthritis-related projects!https://twitter.com/bu_movelab/status/1220454501901131777 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
PRF News--Nav1.7 Channels in DRG Neurons: Where Are They and How Do They Get There? A new study provides the first live visualization, with single-molecule resolution, of Nav1.7 distribution and trafficking along primary afferents. https://buff.ly/2NQ0I2w
@DaraBree1pic.twitter.com/jhyEjJK20l
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
Dear Friends, as promised - here is the first video for myositis patients explaining - What is Myositis? In
#Myositis101 series I will post 1 myositis video each week to promote myositis awareness. Subscribe to YouTube channel Myositis101 for the updates.https://youtu.be/evakulPVWM0Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tuhina Neogi, MD, PhD proslijedio/la je Tweet
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related Diseasehttps://acr.tw/2uoXgVT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.